Business Description
Sunder Biomedical Tech Co Ltd
ISIN : TW0004115001
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.33 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.52 | |||||
Debt-to-EBITDA | 3.13 | |||||
Interest Coverage | 0.93 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.24 | |||||
Beneish M-Score | -2.52 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.4 | |||||
3-Year EBITDA Growth Rate | -20.8 | |||||
3-Year FCF Growth Rate | 26.1 | |||||
3-Year Book Growth Rate | -0.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 41.9 | |||||
9-Day RSI | 43.37 | |||||
14-Day RSI | 44.75 | |||||
6-1 Month Momentum % | -16.39 | |||||
12-1 Month Momentum % | -32.23 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.68 | |||||
Quick Ratio | 1.3 | |||||
Cash Ratio | 0.43 | |||||
Days Inventory | 75.22 | |||||
Days Sales Outstanding | 106.91 | |||||
Days Payable | 19.53 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 4.33 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 15.99 | |||||
Operating Margin % | 1.41 | |||||
Net Margin % | 2.21 | |||||
FCF Margin % | -0.81 | |||||
ROE % | 2.36 | |||||
ROA % | 1.31 | |||||
ROIC % | 0.86 | |||||
ROC (Joel Greenblatt) % | 3.31 | |||||
ROCE % | 3.39 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 34.33 | |||||
PE Ratio without NRI | 42.92 | |||||
PEG Ratio | 15.33 | |||||
PS Ratio | 0.77 | |||||
PB Ratio | 0.8 | |||||
Price-to-Tangible-Book | 0.81 | |||||
Price-to-Operating-Cash-Flow | 9.87 | |||||
EV-to-EBIT | 26.56 | |||||
EV-to-EBITDA | 6.93 | |||||
EV-to-Revenue | 1.11 | |||||
EV-to-FCF | -136.81 | |||||
Price-to-Graham-Number | 1.24 | |||||
Price-to-Net-Current-Asset-Value | 73.57 | |||||
Earnings Yield (Greenblatt) % | 3.77 | |||||
FCF Yield % | -1.07 | |||||
Forward Rate of Return (Yacktman) % | -0.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Sunder Biomedical Tech Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 795.795 | ||
EPS (TTM) (NT$) | 0.3 | ||
Beta | 0 | ||
Volatility % | 24.87 | ||
14-Day RSI | 44.75 | ||
14-Day ATR (NT$) | 0.370793 | ||
20-Day SMA (NT$) | 10.6325 | ||
12-1 Month Momentum % | -32.23 | ||
52-Week Range (NT$) | 9.9 - 16.25 | ||
Shares Outstanding (Mil) | 60 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sunder Biomedical Tech Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sunder Biomedical Tech Co Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Sunder Biomedical Tech Co Ltd Frequently Asked Questions
What is Sunder Biomedical Tech Co Ltd(ROCO:4115)'s stock price today?
When is next earnings date of Sunder Biomedical Tech Co Ltd(ROCO:4115)?
Does Sunder Biomedical Tech Co Ltd(ROCO:4115) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |